Atossa Genetics Valuation
| ATOS Stock | USD 0.56 0.04 6.67% |
Atossa Genetics is fairly valued. Atossa Genetics shows a prevailing Real Value of $0.54 per share. The current price of the firm is $0.56. Our model approximates the value of Atossa Genetics from analyzing the firm fundamentals such as Current Valuation of 24.99 M, shares owned by insiders of 0.32 %, and Return On Equity of -0.49 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Atossa Genetics' price fluctuation is abnormally volatile at this time. Calculation of the real value of Atossa Genetics is based on 3 months time horizon. Increasing Atossa Genetics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Atossa stock is determined by what a typical buyer is willing to pay for full or partial control of Atossa Genetics. Since Atossa Genetics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atossa Stock. However, Atossa Genetics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.56 | Real 0.54 | Hype 0.56 | Naive 0.56 |
The intrinsic value of Atossa Genetics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Atossa Genetics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Atossa Genetics helps investors to forecast how Atossa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atossa Genetics more accurately as focusing exclusively on Atossa Genetics' fundamentals will not take into account other important factors: About Atossa Genetics Valuation
The stock valuation mechanism determines Atossa Genetics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Atossa Genetics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atossa Genetics. We calculate exposure to Atossa Genetics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Atossa Genetics's related companies.Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Atossa Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.